NRF2 regulates HER1 signaling pathway to modulate the sensitivity of ovarian cancer cells to lapatinib and erlotinib

Ibrahim Hamza Kankia
, Hilal S. Khalil
, Simon P. Langdon
, Peter R. Moult
, James L. Bown
, Yusuf Y. Deeni^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

28 Citations (Scopus)

374 Downloads (Pure)

1 results
- Title(descending)
- Award date

Design and development of novel tools for the screening and identification of inhibitors of HER receptor family and NFR2 for ovarian cancer therapy
Hamza Kankia, I. (Author), Moult, P. R. (Supervisor) & Deeni, Y. Y. (Supervisor), 31 Oct 2017
Student thesis: Doctoral Thesis › PhD

File